Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP914085.RAeVppWE0pKaIC4aXzMTYKT3UrJMKqYC-_Lk3wangLl3g130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914085.RAeVppWE0pKaIC4aXzMTYKT3UrJMKqYC-_Lk3wangLl3g130_provenance.
• NP606003.RAR-4Xd-4lLy36xyc40ZWQKLCsc2FCgAlUAl5YMgAngtw130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606003.RAR-4Xd-4lLy36xyc40ZWQKLCsc2FCgAlUAl5YMgAngtw130_provenance.
• NP606034.RAdWCVJkgSM5mDBH3t-rpf17HFaullvg-GFv9iieQSdOs130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606034.RAdWCVJkgSM5mDBH3t-rpf17HFaullvg-GFv9iieQSdOs130_provenance.
• NP978547.RAdoYwxzCvDwig5AveFftB4Nw80UHqw8OvFB5TNTjfaKs130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978547.RAdoYwxzCvDwig5AveFftB4Nw80UHqw8OvFB5TNTjfaKs130_provenance.
• NP978558.RAdYMXh3h4SS6wpNspsgB9UrBCnx8TT4wPyH3cAhh2pwg130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978558.RAdYMXh3h4SS6wpNspsgB9UrBCnx8TT4wPyH3cAhh2pwg130_provenance.
• NP781454.RAr9JYyp9JUtziz8F9ALsW9MZKkz1zWo-MyAGCfHXSuAA130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781454.RAr9JYyp9JUtziz8F9ALsW9MZKkz1zWo-MyAGCfHXSuAA130_provenance.
• NP557463.RACpX5WlI6dYxUW25IpqTyqwot3WONerzCcKg4irfMWpg130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557463.RACpX5WlI6dYxUW25IpqTyqwot3WONerzCcKg4irfMWpg130_provenance.
• NP557474.RARQovlFo3-hMpkmshPX7qKxMcIIPqIbAmY25D9B-Q9G8130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557474.RARQovlFo3-hMpkmshPX7qKxMcIIPqIbAmY25D9B-Q9G8130_provenance.
• NP557475.RAcX_RvVfPnILT_rm4rXoHbppQCWBtn8KwRmcxPya8Kk0130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557475.RAcX_RvVfPnILT_rm4rXoHbppQCWBtn8KwRmcxPya8Kk0130_provenance.
• NP557477.RAWblVj-lloO4kxm7bFeNfznd4BJBjDx3-8tw_zHSkJok130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557477.RAWblVj-lloO4kxm7bFeNfznd4BJBjDx3-8tw_zHSkJok130_provenance.
• NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_provenance.
• NP873233.RAAjMg8IpEGj_Sc_bulXeoTN94mDz1nLjyKjXlm5e9XuU130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873233.RAAjMg8IpEGj_Sc_bulXeoTN94mDz1nLjyKjXlm5e9XuU130_provenance.
• NP606013.RAiVWXgv58GLZIH9WjW58HIdsm2rRE5CeHp6D1iWkkXEE130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606013.RAiVWXgv58GLZIH9WjW58HIdsm2rRE5CeHp6D1iWkkXEE130_provenance.
• NP914043.RAl48McTslERqzqcu_Fi2ZwEeF_yPKhsXlOWL76bloETU130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914043.RAl48McTslERqzqcu_Fi2ZwEeF_yPKhsXlOWL76bloETU130_provenance.
• NP557464.RAkgD_X30Ssmr7I60Tvih1TR5Q5yKqqP3kX-XlA51X-Ec130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557464.RAkgD_X30Ssmr7I60Tvih1TR5Q5yKqqP3kX-XlA51X-Ec130_provenance.
• NP557465.RAlggANuL4cU5fUmf3TpUctyDszF2yXTfL5iW4b9lLn9E130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557465.RAlggANuL4cU5fUmf3TpUctyDszF2yXTfL5iW4b9lLn9E130_provenance.
• NP557468.RAmN4HbI7--OePFS96lP96Zig790nB2kjiJgTarOajhVE130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557468.RAmN4HbI7--OePFS96lP96Zig790nB2kjiJgTarOajhVE130_provenance.
• NP557470.RAtD2d1NPv157KbZVZJMAK8APhxZpcdGXoiDDvlPS5L9o130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557470.RAtD2d1NPv157KbZVZJMAK8APhxZpcdGXoiDDvlPS5L9o130_provenance.
• NP557472.RAm-Jtq6ouQl3l4Q-jBIPngBE76lYhF5cAWkLLO1iVTvY130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557472.RAm-Jtq6ouQl3l4Q-jBIPngBE76lYhF5cAWkLLO1iVTvY130_provenance.
• NP557476.RAlnIdWB-l3c3H8h1_vyGTJ0yCIzZeOCaQEMwE-dLcgHo130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557476.RAlnIdWB-l3c3H8h1_vyGTJ0yCIzZeOCaQEMwE-dLcgHo130_provenance.
• NP873210.RAJaVoXNCY78e2ypqwe_gYWYQlBR0CooUQI12pjU9DXyg130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873210.RAJaVoXNCY78e2ypqwe_gYWYQlBR0CooUQI12pjU9DXyg130_provenance.
• NP557469.RAMJ_0BTNVyJvFr66KTY4uMXJKIr9q8UxRAAyvS-aWjAw130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557469.RAMJ_0BTNVyJvFr66KTY4uMXJKIr9q8UxRAAyvS-aWjAw130_provenance.
• NP781447.RA9MfvHVW5jTxwpWyvUJeVyaRpFgHb7sU1R4OLxYW-Tcc130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781447.RA9MfvHVW5jTxwpWyvUJeVyaRpFgHb7sU1R4OLxYW-Tcc130_provenance.
• NP781470.RAxcrhzduhWvNVadCXfEZ1mXsxlhyIAokKG3IF5vEADB4130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781470.RAxcrhzduhWvNVadCXfEZ1mXsxlhyIAokKG3IF5vEADB4130_provenance.
• NP978575.RA68qbQXm1gGGI_O7kdz6pyQ6_xVCDGZcmfLTdhRASlqY130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978575.RA68qbQXm1gGGI_O7kdz6pyQ6_xVCDGZcmfLTdhRASlqY130_provenance.
• NP914063.RA3n397V_BjN-6RAsUnPKfarQERwRfuoDe0Njb4ttT-NI130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914063.RA3n397V_BjN-6RAsUnPKfarQERwRfuoDe0Njb4ttT-NI130_provenance.
• NP557466.RAxs_kOCmzhVNmnvqFfNvEhEn6g5FDARGs2CAbmJlc8zw130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557466.RAxs_kOCmzhVNmnvqFfNvEhEn6g5FDARGs2CAbmJlc8zw130_provenance.
• NP557467.RA3LmSpKBX0kptUyUNg7WKRPh_rzNOmMIiRilzqx8h2aQ130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557467.RA3LmSpKBX0kptUyUNg7WKRPh_rzNOmMIiRilzqx8h2aQ130_provenance.
• NP557471.RA09mGIjbGw1MN8zUAe1i51lXalEPFsy2oR0N4tcIAPlo130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557471.RA09mGIjbGw1MN8zUAe1i51lXalEPFsy2oR0N4tcIAPlo130_provenance.
• NP557473.RA9g-P3GDB1b1gQRp7r3-FDrx7E4mSP92ZBXb0366b-1Y130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557473.RA9g-P3GDB1b1gQRp7r3-FDrx7E4mSP92ZBXb0366b-1Y130_provenance.